| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/05/2011 | US20110104227 Absorbable polyethylene diglycolate copolymers to reduce microbial adhesion to medical devices and implants |
| 05/05/2011 | US20110104226 Peptides having binding affinity to an antibody which recognizes an epitope on an a1 loop 2 or beta2 loop 1 of an adrenoreceptor |
| 05/05/2011 | US20110104215 Transdermally absorbable preparation |
| 05/05/2011 | US20110104214 Once-a-day oxycodone formulations |
| 05/05/2011 | US20110104213 Porous Biomolecule-Containing Metal-Organic Frameworks |
| 05/05/2011 | US20110104212 Polymeric compositions with enhanced saline holding capacity and their method of preparation and use |
| 05/05/2011 | US20110104208 Enzyme Treatment of Glucans |
| 05/05/2011 | US20110104207 Gyrase inhibitors and uses thereof |
| 05/05/2011 | US20110104206 Methods and compositions for sustained delivery of drugs |
| 05/05/2011 | US20110104189 Compositions obtained from chlorella extract having immunomodulating properties |
| 05/05/2011 | US20110104188 Novel glycolipid and use thereof |
| 05/05/2011 | US20110104186 Small molecule immunopotentiators and assays for their detection |
| 05/05/2011 | US20110104183 Use of sip1 as determinant of breast cancer stemness |
| 05/05/2011 | US20110104181 Modulation of synaptogenesis |
| 05/05/2011 | US20110104177 Histone deacetylase inhibitors, combination therapies and methods of use |
| 05/05/2011 | US20110104173 Inhibition of degradation of extracellular matrix |
| 05/05/2011 | US20110104172 Inhibitors of gm-csf and il-17 for therapy |
| 05/05/2011 | US20110104169 Regulator genes of angiogenesis, pharmaceutical preparations containing them and their applications |
| 05/05/2011 | US20110104167 Compositions and Methods for Diagnosing and Treating Insulin Resistance |
| 05/05/2011 | US20110104166 Methods and Compositions for Treating Polyps |
| 05/05/2011 | US20110104165 Method of upregulating sorla for the treatment of alzheimer's disease |
| 05/05/2011 | US20110104162 Compounds which can be used for the Treatment of Cancers |
| 05/05/2011 | US20110104161 Combinations vegf(r) inhibitors and hepatocyte growth factor (c-met) inhibitors for the treatment of cancer |
| 05/05/2011 | US20110104159 Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy |
| 05/05/2011 | US20110104158 Deuterium bearing analogs of anastrozole as aromatase inhibitors for the treatment of breast cancer |
| 05/05/2011 | US20110104156 Methods and materials for treating autoimmune and/or complement mediated diseases and conditions |
| 05/05/2011 | US20110104155 Drug delivery to the anterior and posterior segments of the eye using eye drops |
| 05/05/2011 | US20110104149 SingleC-9 Binding Agents |
| 05/05/2011 | US20110104147 Identification of Tumor-Associated Markers for Diagnosis and Therapy |
| 05/05/2011 | US20110104146 Antithrombotic agents and methods of use thereof |
| 05/05/2011 | US20110104144 Methods for treating cutaneous lupus using aminoisoindoline compounds |
| 05/05/2011 | US20110104138 Use of the innate immunity gene oasl for preventing or treating infection with negative strand rna viruses |
| 05/05/2011 | US20110104137 ADJUNCTS AND COMPLEXES FOR IMPROVING HMG-CoA REDUCTASE INHIBITOR (STATIN) AND SELECTIVE PHOSPHODIESTERASE 5 INHIBITOR THERAPY |
| 05/05/2011 | US20110104136 Natural Killer p30 (NKp30) Dysfunction and the Biological Applications Thereof |
| 05/05/2011 | US20110104130 Thymidylate kinase fusions and uses thereof |
| 05/05/2011 | US20110104129 T cell receptors and related materials and methods of use |
| 05/05/2011 | US20110104121 Female Reproductive Tract and Anal Prophylaxes |
| 05/05/2011 | US20110104120 Directed Evolution and In Vivo Panning of Virus Vectors |
| 05/05/2011 | US20110104115 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 05/05/2011 | US20110104110 Substituted indole derivatives and methods of use thereof |
| 05/05/2011 | US20110104109 Tetracyclic indole derivatives and their use for treating or preventing viral infections |
| 05/05/2011 | US20110104108 Methods of treating cancer and other conditions or disease states using lfmau and ldt |
| 05/05/2011 | US20110104103 Method of conjugating therapeutic compounds to cell targeting devices via metal complexes |
| 05/05/2011 | US20110104083 Methods and cosmetic preparations for the sustained delivery of therapeutic agents to the eye |
| 05/05/2011 | US20110104080 Oral Compositions for Treatment of Dry Mouth |
| 05/05/2011 | US20110104066 Prophylactic/therapeutic agents for lifestyle-related diseases |
| 05/05/2011 | US20110104065 Genetic alteration associated with pre-malignant cancer |
| 05/05/2011 | US20110104060 Treatment of hypertension by renal vascular delivery of guanethidine |
| 05/05/2011 | US20110104057 Novel [F-18]-labelled L-glutamic acid and L-glutamine derivatives (II), their use and processes for their preparation |
| 05/05/2011 | US20110104055 Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies |
| 05/05/2011 | US20110104054 Small-Molecule HSP90 Inhibitors |
| 05/05/2011 | US20110104052 Methods of synthesis and use of chemospheres |
| 05/05/2011 | US20110104050 Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin |
| 05/05/2011 | US20110100371 Anti-viral properties of zosteric acid and related molecules |
| 05/05/2011 | US20110100361 Pressurised metered dose inhalers (mdi) |
| 05/05/2011 | DE10340417C5 Kosmetische oder dermatologische Zubereitung mit Phytosterolen in Form einer W/O-Emulsion Cosmetic or dermatological preparation with phytosterols in the form of a W / O emulsion |
| 05/05/2011 | DE10311106B4 Peptide gegen Kälteunverträglichkeit hervorrufende Autoantikörper, dafür kodierende Nukleinsäuren, ihre Verwendung und diese umfassende pharmazeutische Zusammensetzungen Peptides against cold intolerance inducing autoantibodies, nucleic acids encoding, their use and pharmaceutical compositions comprising |
| 05/05/2011 | DE102009051799A1 Bifunktionale Prodrugs und Drugs Bifunctional prodrugs and Drugs |
| 05/05/2011 | DE102009051066A1 Composition, useful for preparing a drug for treating e.g. limbs-, tendon-, muscle pain, comprises a carrier medium, menthol, horse chestnut seed extract, white willow bark extract, Arnica tincture, rosemary oil and St. John's wort oil |
| 05/05/2011 | DE102009050308A1 New polyribonucleotide, having protein encoding sequence that comprises combination of unmodified and modified nucleotides and is obtained from mixture of ATP, guanosine-, cytidine- and uridine-triphosphate, useful e.g. for coating implant |
| 05/05/2011 | DE102009027754A1 Verfahren zur Hemmung der Reifung von dendritischen Zellen A method of inhibiting the maturation of dendritic cells |
| 05/05/2011 | CA2790975A1 Compositions comprising flavonoid-containing extracts from plants of the genus citrus and/or isolated citrus flavonoids and specific cationic surface active agents, and said composition for use as an agent for treating infestations with head lice |
| 05/05/2011 | CA2785687A1 Composition containing fesoterodine and fibers |
| 05/05/2011 | CA2779518A1 Gastroretentive oral high dose zinc preparations |
| 05/05/2011 | CA2779497A1 The use of ci-994 and dinaline for the treatment of memory/cognition and anxiety disorders |
| 05/05/2011 | CA2779473A1 Methods of treating viral associated diseases |
| 05/05/2011 | CA2779452A1 2-aminoindole compounds and methods for the treatment of malaria |
| 05/05/2011 | CA2779400A1 Compositions and methods for treating dermatological conditions |
| 05/05/2011 | CA2779398A1 Novel 3-hydroxy-5-arylisoxazole derivative |
| 05/05/2011 | CA2779316A1 Paclitaxel/steroidal compound |
| 05/05/2011 | CA2779268A1 Acylamino-substituted cyclic carboxylic acid derivatives and their use as pharmaceuticals |
| 05/05/2011 | CA2779244A1 Dosage regimens for hcv combination therapy comprising bi201335, interferon alpha and ribavirin |
| 05/05/2011 | CA2779177A1 Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands |
| 05/05/2011 | CA2779166A1 Submicro emulsion of paclitaxel using steroid complex as intermediate carrier |
| 05/05/2011 | CA2779162A1 Concentrated therapeutic phospholipid compositions |
| 05/05/2011 | CA2779160A1 Use of ferroquine in the treatment or prevention of malaria |
| 05/05/2011 | CA2779124A1 Heteroaryl substituted arylindenopyrimidines and their use as highly selective adenosine a2a receptor antagonists |
| 05/05/2011 | CA2779120A1 Heterocyclyl substituted arylindenopy-rimidines and their use as highly selective adenosine a2a receptor antagonists |
| 05/05/2011 | CA2779111A1 Dimethyl sulfoxide (dmso) and methylsulfonylmethane (msm) formulations to treat osteoarthritis |
| 05/05/2011 | CA2779108A1 4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators |
| 05/05/2011 | CA2779107A1 Pyrimidine compounds as delta opioid receptor modulators |
| 05/05/2011 | CA2779105A1 Kinase inhibitors |
| 05/05/2011 | CA2779099A1 Templated nanoconjugates |
| 05/05/2011 | CA2779097A1 Aryl substituted arylindenopyrimidines and their use as highly selective adenosine a2a receptor antagonists |
| 05/05/2011 | CA2779096A1 Methods for treating parkinson's disease |
| 05/05/2011 | CA2779095A1 Alkyl substituted arylindenopyrimidines and their use as highly selective adenosine a2a receptor antagonists |
| 05/05/2011 | CA2779091A1 2-amino-9-[4-(4-methoxy-phenoxy)-piperidin-1-yl]-4-phenyl-indeno[1,2-d]pyrimidin-5-one and its use as a highly selective adenosine a2a receptor antagonist |
| 05/05/2011 | CA2779083A1 Pyrazines as delta opioid receptor modulators |
| 05/05/2011 | CA2779073A1 Novel oxime derivatives and their use as allosteric modulators of metabotropic glutamate receptors |
| 05/05/2011 | CA2779063A1 Methods of treating or preventing acute erythema |
| 05/05/2011 | CA2779025A1 Therapeutic uses of oligomeric and polymeric monoterpenes |
| 05/05/2011 | CA2779009A1 Novel antitumoral use of cabazitaxel |
| 05/05/2011 | CA2778981A1 Solid dispersion of rifaximin |
| 05/05/2011 | CA2778979A1 Phenoxy-substituted pyrimidines as opioid receptor modulators |
| 05/05/2011 | CA2778949A1 Imidazo[1,2-b]pyridazine derivatives and their use as pde10 inhibitors |
| 05/05/2011 | CA2778884A1 Preparation comprising amino acids and plants and its activity in the alcohol detoxification |
| 05/05/2011 | CA2778807A1 Methods of preparing 1-(4-((1r,2s,3r)-1,2,3,4-tetrahydroxybutyl)-1h-imidazol-2-yl)ethanone |
| 05/05/2011 | CA2778756A1 Benzazepine compound |
| 05/05/2011 | CA2778689A1 Transdermal pharmaceutical compositions comprising active agents |
| 05/05/2011 | CA2778684A1 Bridged bicyclic piperidine derivatives and methods of use thereof |